MedPath

CHULALONGKORN UNIVERSITY

🇹🇭Thailand
Ownership
-
Established
1917-01-01
Employees
-
Market Cap
-
Website
https://www.chula.ac.th/

Clinical Trials

401

Active:11
Completed:215

Trial Phases

6 Phases

Early Phase 1:1
Phase 1:40
Phase 2:39
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (324 trials with phase data)• Click on a phase to view related trials

Not Applicable
162 (50.0%)
Phase 4
46 (14.2%)
Phase 1
40 (12.3%)
Phase 2
39 (12.0%)
Phase 3
36 (11.1%)
Early Phase 1
1 (0.3%)

Multi-centred Clinico-genetic Study of Actinic Prurigo in Thailand

Recruiting
Conditions
Actinic Prurigo
First Posted Date
2025-07-08
Last Posted Date
2025-07-08
Lead Sponsor
Chulalongkorn University
Target Recruit Count
47
Registration Number
NCT07055009
Locations
🇹🇭

Faculty of Medicine Chulalongkorn University, Bangkok, Thailand

Facilitators and Barriers to Eptinezumab Administration in Thailand

Not yet recruiting
Conditions
Migraine
Treatment
Treatment Refusal
Interventions
Other: Sham (No Treatment)
First Posted Date
2025-06-25
Last Posted Date
2025-06-25
Lead Sponsor
Chulalongkorn University
Target Recruit Count
30
Registration Number
NCT07035197
Locations
🇹🇭

King Chualongkorn Memorial Hospital, the Thai Red Cross Society, Bangkok, Thailand

Efficacy of Itopride Versus Metoclopramide in Hospitalized Medicine Patients With High Gastric Residual Volume

Phase 4
Not yet recruiting
Conditions
Feeding Intolerance
Interventions
First Posted Date
2025-06-22
Last Posted Date
2025-06-22
Lead Sponsor
Chulalongkorn University
Target Recruit Count
86
Registration Number
NCT07031479

Exploring Different Dose-frequency Home Photodynamic Therapy Protocols Using a Novel Home-targeted LED Device for Onychomycosis

Not Applicable
Active, not recruiting
Conditions
Onychomycosis of Toenails
Onychomycosis of Fingernail
Interventions
Radiation: Photodynamic Therapy with Conventional Methylene Blue
First Posted Date
2025-06-10
Last Posted Date
2025-07-09
Lead Sponsor
Chulalongkorn University
Target Recruit Count
50
Registration Number
NCT07012343
Locations
🇹🇭

Faculty of Medicine Chulalongkorn University, Bangkok, Thailand

The Therapeutic Effect of Curcumin in Nanogels Compared to 0.1% FAO in the Management of Oral Lichen Planus

Not Applicable
Not yet recruiting
Conditions
Oral Lichen Planus
Interventions
Drug: Curcumin in Nanogels
Drug: 0.1% Fluocinolone Acetonide Oral Paste
First Posted Date
2025-04-17
Last Posted Date
2025-04-22
Lead Sponsor
Chulalongkorn University
Target Recruit Count
30
Registration Number
NCT06932848
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 57
  • Next

News

No news found
© Copyright 2025. All Rights Reserved by MedPath